FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia ; volume:16 ; number:1 ; day:11 ; month:2 ; year:2023 ; pages:1-22 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (11.2.2023), 1-22, 12.2023
- Creator
-
Zhu, Xiao-Na
Wei, Yu-Sheng
Yang, Qian
Liu, Hao-Ran
Zhi, Zhe
Zhu, Di
Xia, Li
Hong, Deng-Li
Yu, Yun
Chen, Guo-Qiang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01400-0
- URN
-
urn:nbn:de:101:1-2023041509170078884344
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Xiao-Na
- Wei, Yu-Sheng
- Yang, Qian
- Liu, Hao-Ran
- Zhi, Zhe
- Zhu, Di
- Xia, Li
- Hong, Deng-Li
- Yu, Yun
- Chen, Guo-Qiang
- SpringerLink (Online service)
Other Objects (12)
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Using genome editing to model MLL rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Using genome editing to model MLL rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia